To avoid wasting valuable resources developing drugs that will fail, it’s crucial to identify the likelihood of success as early as possible. However, collating the necessary data to perform this analysis is a constant challenge.
Avoid late-stage failures by accessing the broadest, deepest, most accurate source of R&D intelligence that has been manually curated, validated, and shared using a solution built by scientists for scientists. Cortellis Drug Discovery Intelligence™ focuses exclusively on pharma and drug development intelligence, harmonizing and integrating essential biological, chemical, and pharmacological data from disparate sources into a single platform.
Supplement and enhance your searches with fully integrated information on companies and research institutes, current biomedical literature, and the most recent patient literature.
"If you don’t have [Cortellis Drug Discovery Intelligence], you may never find the information you need. It’s that critical."
Seamlessly link from Cortellis Drug Discovery Intelligence to other reputable scientific resources and enhance your work with a wide range of search, browse and export choices.
"I find direct access to the literature and patents via [Cortellis Drug Discovery Intelligence] to be useful, too."
This optional module brings an added dimension to your research by linking drugs, targets, and genes to biomarkers information from a diverse range of sources.
"[Cortellis Drug Discovery Intelligence] provides extended (multi-aspect) coverage exceeding the capabilities of its competitors."
The wealth of scientific pipeline data contains granular target and MOA information as well as the most extensive pre-clinical and clinical biomarker data linked to associated diseases and therapies – all of which is easily searchable in one platform.
"[Cortellis Drug Discovery Intelligence] provides the most reliable multi-faceted information about human medicines under study from a single source."
One-click, user-friendly suite of applications that integrate the three major steps of pre-clinical research into a single cloud-based workflow. Get a reliable, quick, and comprehensive view of an indication and its potential.
"We have tried other research databases, including those in the public domain, but have always come back to [Cortellis Drug Discovery Intelligence]."
Help drive innovation and support earlier decision-making when developing new hypotheses for new targets, drugs and biomarkers.
Access key information from hard data points – not just references – from in vitro and in vivo pharmacological assays and pharmacokinetics studies.
Avoid costly mistakes and learn from the success of your peers with comprehensive coverage of pipeline data, patents, literature, and conferences – all from a scientific perspective.
Stay current with the latest developments without wasting time reviewing irrelevant materials by leveraging pre-clinical drug information that is updated and consolidated daily into a single, flexible resource.
Gain context for your R&D efforts with dynamic disease- and disorder-specific summaries on current treatments and future trends that include risk factors, prevalence, morbidity, mortality, and current treatments.
Drugs and biologics
Targets and genes
Pharmacology data points
Our accredited global alliance program delivers value-added solutions by combining offerings from Clarivate with other technology and service providers. Partner with us to drive profitable growth, increase revenue and deliver greater value to your customers.
Receive daily insights on the latest biopharma news and medical technology advances to better inform crucial R&D decisions at the earliest research stages.
Contact us to schedule a demo of Cortellis Drug Discovery Intelligence.